A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B
NCT02600975
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
BIOLOGICAL:
R21 with ASO1B
Sponsor
University of Oxford